Follow The Filings

ADMA ADMA Biologics

ADMA Biologics earnings company data as of 4:45 AM ET 11/6

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 0.19 0.22 Beat +15.8%
Rev $138.1M $141.1M Beat +2.2%

Insider trades

Open-market buys and sales by ADMA's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ADMA insider trades
  • $468K bought by 2 insiders
  • $158K sold by 1 insider outside a trading plan
  • $3.2M sold by 1 insider under 10b5-1 plans
  1. Adam S Grossman CEO
    Planned sale
    $1.8M 147,000 shares at $12.00 6.6% of stake
    Traded Nov 5 Filed Nov 5
  2. Jerrold B Grossman Director
    Buy
    $51K 6,400 shares at $7.91 +1.2% to stake
    Traded May 27 Filed May 28
  3. Jerrold B Grossman Director
    Buy
    $100K 12,500 shares at $8.01 +2.5% to stake
    Traded May 12 Filed May 14
  4. Jerrold B Grossman Director
    Buy
    $100K 12,500 shares at $8.01 +2.6% to stake
    Traded May 11 Filed May 12
  5. Adam S Grossman CEO
    Planned sale
    $318K 21,000 shares at $15.16 1% of stake
    Traded Mar 16 Filed Mar 17
  6. Kaitlin M. Kestenberg-Messina COO
    Sale
    $158K 10,096 shares at $15.63 2.1% of stake
    Traded Mar 9 Filed Mar 10
  7. Steve Elms Director
    Buy
    $217K 14,000 shares at $15.53 +0.7% to stake
    Traded Mar 5–6 Filed Mar 9
  8. Adam S Grossman CEO
    Planned sale
    $338K 21,000 shares at $16.08 0.9% of stake
    Traded Feb 17 Filed Feb 17
  9. Adam S Grossman CEO
    Planned sale
    $416K 21,000 shares at $19.79 1% of stake
    Traded Dec 15, 2025 Filed Dec 16, 2025
  10. Adam S Grossman CEO
    Planned sale
    $336K 21,000 shares at $16.00 1% of stake
    Traded Nov 19, 2025 Filed Nov 21, 2025
  11. Adam S Grossman CEO
    Planned sale
    $336K 21,000 shares at $16.00 1% of stake
    Traded Oct 24, 2025 Filed Oct 24, 2025

Also filed in the last 12 months, not counted as buying or selling: 11 option exercises, 10 share withholdings for taxes, 9 stock grants, 2 gifts, and 1 other transaction.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 2.02,9.01
10-Q
8-K 8.01,9.01
SCHEDULE 13G —
DEF 14A
DEFA14A
8-K 7.01,9.01
SCHEDULE 13G/A —
8-K 7.01,8.01,9.01
8-K 2.02,5.02,9.01
10-K
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf